Two-year adherence and costs for biologic therapy for rheumatoid arthritis.

CONCLUSIONS: Adherence to the first bDMARD was suboptimal even in effectively treated patients, suggesting opportunities to improve adherence in patients with RA initiating biologics.
PMID: 30020744 [PubMed - in process]

Source: The American Journal of Managed Care - July 1, 2018 Category: Health Management Authors: Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J Tags: Am J Manag Care Source Type: research